MedWatch

Dexcom rolls out new glucose monitor in Europe

The company has already entered a partnership with fitness tracker manufacturers like Garmin to use the new devices to measure physical activity in people with type 2 diabetes.

The depcted G6 glucose monitoring device will soon be succeeded by a newer, smaller version on the European market | Photo: Dexcom

Dexcom, a US-based medtech company and Novo Nordisk partner, is launching its newest generation of glucose monitors, dubbed G7, on the European market, industry media Fierce Pharma reports.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs